Carmustine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00262 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 11 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | lymph node cancer | KG + DL |
| 2 | astrocytoma (excluding glioblastoma) | KG + DL |
| 3 | adult astrocytic tumour | KG + DL |
| 4 | cauda equina neoplasm | KG + DL |
| 5 | reticulum cell sarcoma | KG + DL |
| 6 | childhood cerebral astrocytoma | KG + DL |
| 7 | subependymal giant cell astrocytoma | KG + DL |
| 8 | astrocytic tumor | KG + DL |
| 9 | interdigitating dendritic cell sarcoma | KG + DL |
| 10 | colon adenocarcinoma | KG + DL |
| 11 | subcutaneous panniculitis-like T-cell lymphoma | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.